nodes	percent_of_prediction	percent_of_DWPC	metapath
Potassium Canrenoate—Paralysis flaccid—Chlorambucil—testicular cancer	0.0739	0.0739	CcSEcCtD
Potassium Canrenoate—Areflexia—Cisplatin—testicular cancer	0.0511	0.0511	CcSEcCtD
Potassium Canrenoate—Venous thrombosis—Carboplatin—testicular cancer	0.0437	0.0437	CcSEcCtD
Potassium Canrenoate—Fluid overload—Carboplatin—testicular cancer	0.0379	0.0379	CcSEcCtD
Potassium Canrenoate—Gastrointestinal ulcer haemorrhage—Cisplatin—testicular cancer	0.0361	0.0361	CcSEcCtD
Potassium Canrenoate—Extravasation—Carboplatin—testicular cancer	0.027	0.027	CcSEcCtD
Potassium Canrenoate—Phlebitis—Carboplatin—testicular cancer	0.0199	0.0199	CcSEcCtD
Potassium Canrenoate—Paresthesia of limbs—Methotrexate—testicular cancer	0.0198	0.0198	CcSEcCtD
Potassium Canrenoate—Gastrointestinal ulcer haemorrhage—Methotrexate—testicular cancer	0.0198	0.0198	CcSEcCtD
Potassium Canrenoate—Ileus—Vinblastine—testicular cancer	0.0157	0.0157	CcSEcCtD
Potassium Canrenoate—Slurred speech—Cisplatin—testicular cancer	0.0155	0.0155	CcSEcCtD
Potassium Canrenoate—Venous thrombosis—Cisplatin—testicular cancer	0.0128	0.0128	CcSEcCtD
Potassium Canrenoate—Extravasation—Vinblastine—testicular cancer	0.0127	0.0127	CcSEcCtD
Potassium Canrenoate—Ileus—Ifosfamide—testicular cancer	0.0113	0.0113	CcSEcCtD
Potassium Canrenoate—Fluid overload—Cisplatin—testicular cancer	0.0111	0.0111	CcSEcCtD
Potassium Canrenoate—Extravasation—Bleomycin—testicular cancer	0.0108	0.0108	CcSEcCtD
Potassium Canrenoate—Extravasation—Dactinomycin—testicular cancer	0.01	0.01	CcSEcCtD
Potassium Canrenoate—Ulcer—Bleomycin—testicular cancer	0.00993	0.00993	CcSEcCtD
Potassium Canrenoate—Phlebitis—Vinblastine—testicular cancer	0.00937	0.00937	CcSEcCtD
Potassium Canrenoate—Ulcer—Dactinomycin—testicular cancer	0.00926	0.00926	CcSEcCtD
Potassium Canrenoate—Extravasation—Ifosfamide—testicular cancer	0.0092	0.0092	CcSEcCtD
Potassium Canrenoate—Dysarthria—Ifosfamide—testicular cancer	0.00848	0.00848	CcSEcCtD
Potassium Canrenoate—Infection—Carboplatin—testicular cancer	0.00836	0.00836	CcSEcCtD
Potassium Canrenoate—Extravasation—Cisplatin—testicular cancer	0.00793	0.00793	CcSEcCtD
Potassium Canrenoate—Phlebitis—Bleomycin—testicular cancer	0.00791	0.00791	CcSEcCtD
Potassium Canrenoate—Phlebitis—Dactinomycin—testicular cancer	0.00738	0.00738	CcSEcCtD
Potassium Canrenoate—Dysarthria—Cisplatin—testicular cancer	0.00731	0.00731	CcSEcCtD
Potassium Canrenoate—Ulcer—Cisplatin—testicular cancer	0.00731	0.00731	CcSEcCtD
Potassium Canrenoate—Extravasation—Etoposide—testicular cancer	0.00726	0.00726	CcSEcCtD
Potassium Canrenoate—Pain—Carboplatin—testicular cancer	0.00719	0.00719	CcSEcCtD
Potassium Canrenoate—Hyperkalaemia—Cisplatin—testicular cancer	0.0068	0.0068	CcSEcCtD
Potassium Canrenoate—Phlebitis—Ifosfamide—testicular cancer	0.00676	0.00676	CcSEcCtD
Potassium Canrenoate—Ulcer—Etoposide—testicular cancer	0.0067	0.0067	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Carboplatin—testicular cancer	0.00665	0.00665	CcSEcCtD
Potassium Canrenoate—Venous thrombosis—Epirubicin—testicular cancer	0.00658	0.00658	CcSEcCtD
Potassium Canrenoate—Venous thrombosis—Doxorubicin—testicular cancer	0.00609	0.00609	CcSEcCtD
Potassium Canrenoate—Phlebitis—Cisplatin—testicular cancer	0.00583	0.00583	CcSEcCtD
Potassium Canrenoate—Haemoglobin—Vinblastine—testicular cancer	0.00561	0.00561	CcSEcCtD
Potassium Canrenoate—Haemorrhage—Vinblastine—testicular cancer	0.00558	0.00558	CcSEcCtD
Potassium Canrenoate—Cardiac arrest—Ifosfamide—testicular cancer	0.00554	0.00554	CcSEcCtD
Potassium Canrenoate—Phlebitis—Etoposide—testicular cancer	0.00534	0.00534	CcSEcCtD
Potassium Canrenoate—Ileus—Epirubicin—testicular cancer	0.00502	0.00502	CcSEcCtD
Potassium Canrenoate—Haemoglobin—Bleomycin—testicular cancer	0.00474	0.00474	CcSEcCtD
Potassium Canrenoate—Haemorrhage—Bleomycin—testicular cancer	0.00471	0.00471	CcSEcCtD
Potassium Canrenoate—Ileus—Doxorubicin—testicular cancer	0.00464	0.00464	CcSEcCtD
Potassium Canrenoate—Cardiac arrest—Etoposide—testicular cancer	0.00437	0.00437	CcSEcCtD
Potassium Canrenoate—Confusional state—Chlorambucil—testicular cancer	0.00436	0.00436	CcSEcCtD
Potassium Canrenoate—Extravasation—Methotrexate—testicular cancer	0.00435	0.00435	CcSEcCtD
Potassium Canrenoate—Infection—Chlorambucil—testicular cancer	0.0043	0.0043	CcSEcCtD
Potassium Canrenoate—Abdominal discomfort—Cisplatin—testicular cancer	0.00416	0.00416	CcSEcCtD
Potassium Canrenoate—Discomfort—Vinblastine—testicular cancer	0.00409	0.00409	CcSEcCtD
Potassium Canrenoate—Extravasation—Epirubicin—testicular cancer	0.00407	0.00407	CcSEcCtD
Potassium Canrenoate—Haemoglobin—Ifosfamide—testicular cancer	0.00405	0.00405	CcSEcCtD
Potassium Canrenoate—Haemorrhage—Ifosfamide—testicular cancer	0.00403	0.00403	CcSEcCtD
Potassium Canrenoate—Dysarthria—Methotrexate—testicular cancer	0.00401	0.00401	CcSEcCtD
Potassium Canrenoate—Ulcer—Methotrexate—testicular cancer	0.00401	0.00401	CcSEcCtD
Potassium Canrenoate—Extravasation—Doxorubicin—testicular cancer	0.00377	0.00377	CcSEcCtD
Potassium Canrenoate—Dysarthria—Epirubicin—testicular cancer	0.00376	0.00376	CcSEcCtD
Potassium Canrenoate—Ulcer—Epirubicin—testicular cancer	0.00376	0.00376	CcSEcCtD
Potassium Canrenoate—Pain—Chlorambucil—testicular cancer	0.0037	0.0037	CcSEcCtD
Potassium Canrenoate—Atrioventricular block—Epirubicin—testicular cancer	0.00366	0.00366	CcSEcCtD
Potassium Canrenoate—Arrhythmia—Ifosfamide—testicular cancer	0.0036	0.0036	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Chlorambucil—testicular cancer	0.00357	0.00357	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Vinblastine—testicular cancer	0.00356	0.00356	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Chlorambucil—testicular cancer	0.00354	0.00354	CcSEcCtD
Potassium Canrenoate—Hyperkalaemia—Epirubicin—testicular cancer	0.00349	0.00349	CcSEcCtD
Potassium Canrenoate—Ulcer—Doxorubicin—testicular cancer	0.00347	0.00347	CcSEcCtD
Potassium Canrenoate—Dysarthria—Doxorubicin—testicular cancer	0.00347	0.00347	CcSEcCtD
Potassium Canrenoate—Discomfort—Bleomycin—testicular cancer	0.00345	0.00345	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Chlorambucil—testicular cancer	0.00342	0.00342	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Chlorambucil—testicular cancer	0.00342	0.00342	CcSEcCtD
Potassium Canrenoate—Pain—Vinblastine—testicular cancer	0.00339	0.00339	CcSEcCtD
Potassium Canrenoate—Atrioventricular block—Doxorubicin—testicular cancer	0.00339	0.00339	CcSEcCtD
Potassium Canrenoate—Confusional state—Bleomycin—testicular cancer	0.00338	0.00338	CcSEcCtD
Potassium Canrenoate—Infection—Bleomycin—testicular cancer	0.00333	0.00333	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Vinblastine—testicular cancer	0.00327	0.00327	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Vinblastine—testicular cancer	0.00324	0.00324	CcSEcCtD
Potassium Canrenoate—Hyperkalaemia—Doxorubicin—testicular cancer	0.00323	0.00323	CcSEcCtD
Potassium Canrenoate—Discomfort—Dactinomycin—testicular cancer	0.00322	0.00322	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Vinblastine—testicular cancer	0.00313	0.00313	CcSEcCtD
Potassium Canrenoate—Hypotension—Bleomycin—testicular cancer	0.00313	0.00313	CcSEcCtD
Potassium Canrenoate—Asthenia—Chlorambucil—testicular cancer	0.0031	0.0031	CcSEcCtD
Potassium Canrenoate—Infection—Dactinomycin—testicular cancer	0.0031	0.0031	CcSEcCtD
Potassium Canrenoate—Arrhythmia—Cisplatin—testicular cancer	0.0031	0.0031	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Bleomycin—testicular cancer	0.00301	0.00301	CcSEcCtD
Potassium Canrenoate—Phlebitis—Epirubicin—testicular cancer	0.00299	0.00299	CcSEcCtD
Potassium Canrenoate—Flatulence—Cisplatin—testicular cancer	0.00298	0.00298	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Chlorambucil—testicular cancer	0.00296	0.00296	CcSEcCtD
Potassium Canrenoate—Discomfort—Ifosfamide—testicular cancer	0.00295	0.00295	CcSEcCtD
Potassium Canrenoate—Confusional state—Ifosfamide—testicular cancer	0.00289	0.00289	CcSEcCtD
Potassium Canrenoate—Pain—Bleomycin—testicular cancer	0.00286	0.00286	CcSEcCtD
Potassium Canrenoate—Asthenia—Vinblastine—testicular cancer	0.00285	0.00285	CcSEcCtD
Potassium Canrenoate—Infection—Ifosfamide—testicular cancer	0.00284	0.00284	CcSEcCtD
Potassium Canrenoate—Phlebitis—Doxorubicin—testicular cancer	0.00277	0.00277	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Bleomycin—testicular cancer	0.00276	0.00276	CcSEcCtD
Potassium Canrenoate—Vomiting—Chlorambucil—testicular cancer	0.00275	0.00275	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Vinblastine—testicular cancer	0.00271	0.00271	CcSEcCtD
Potassium Canrenoate—Hypotension—Ifosfamide—testicular cancer	0.00267	0.00267	CcSEcCtD
Potassium Canrenoate—Pain—Dactinomycin—testicular cancer	0.00267	0.00267	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Bleomycin—testicular cancer	0.00265	0.00265	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Dactinomycin—testicular cancer	0.00257	0.00257	CcSEcCtD
Potassium Canrenoate—Nausea—Chlorambucil—testicular cancer	0.00257	0.00257	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Ifosfamide—testicular cancer	0.00257	0.00257	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Dactinomycin—testicular cancer	0.00255	0.00255	CcSEcCtD
Potassium Canrenoate—Discomfort—Cisplatin—testicular cancer	0.00254	0.00254	CcSEcCtD
Potassium Canrenoate—Vomiting—Vinblastine—testicular cancer	0.00252	0.00252	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Dactinomycin—testicular cancer	0.00247	0.00247	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Dactinomycin—testicular cancer	0.00247	0.00247	CcSEcCtD
Potassium Canrenoate—Cardiac arrest—Epirubicin—testicular cancer	0.00245	0.00245	CcSEcCtD
Potassium Canrenoate—Infection—Cisplatin—testicular cancer	0.00245	0.00245	CcSEcCtD
Potassium Canrenoate—Pain—Ifosfamide—testicular cancer	0.00245	0.00245	CcSEcCtD
Potassium Canrenoate—Asthenia—Bleomycin—testicular cancer	0.0024	0.0024	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Ifosfamide—testicular cancer	0.00236	0.00236	CcSEcCtD
Potassium Canrenoate—Nausea—Vinblastine—testicular cancer	0.00236	0.00236	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Ifosfamide—testicular cancer	0.00234	0.00234	CcSEcCtD
Potassium Canrenoate—Discomfort—Etoposide—testicular cancer	0.00233	0.00233	CcSEcCtD
Potassium Canrenoate—Hypotension—Cisplatin—testicular cancer	0.00231	0.00231	CcSEcCtD
Potassium Canrenoate—Abdominal discomfort—Methotrexate—testicular cancer	0.00228	0.00228	CcSEcCtD
Potassium Canrenoate—Confusional state—Etoposide—testicular cancer	0.00228	0.00228	CcSEcCtD
Potassium Canrenoate—Cardiac arrest—Doxorubicin—testicular cancer	0.00227	0.00227	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Ifosfamide—testicular cancer	0.00226	0.00226	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Ifosfamide—testicular cancer	0.00226	0.00226	CcSEcCtD
Potassium Canrenoate—Infection—Etoposide—testicular cancer	0.00225	0.00225	CcSEcCtD
Potassium Canrenoate—Asthenia—Dactinomycin—testicular cancer	0.00224	0.00224	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Cisplatin—testicular cancer	0.00222	0.00222	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Dactinomycin—testicular cancer	0.00214	0.00214	CcSEcCtD
Potassium Canrenoate—Vomiting—Bleomycin—testicular cancer	0.00213	0.00213	CcSEcCtD
Potassium Canrenoate—Hypotension—Etoposide—testicular cancer	0.00211	0.00211	CcSEcCtD
Potassium Canrenoate—Rash—Bleomycin—testicular cancer	0.00211	0.00211	CcSEcCtD
Potassium Canrenoate—Pain—Cisplatin—testicular cancer	0.00211	0.00211	CcSEcCtD
Potassium Canrenoate—Dermatitis—Bleomycin—testicular cancer	0.00211	0.00211	CcSEcCtD
Potassium Canrenoate—Asthenia—Ifosfamide—testicular cancer	0.00205	0.00205	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Cisplatin—testicular cancer	0.00203	0.00203	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Etoposide—testicular cancer	0.00203	0.00203	CcSEcCtD
Potassium Canrenoate—Nausea—Bleomycin—testicular cancer	0.00199	0.00199	CcSEcCtD
Potassium Canrenoate—Vomiting—Dactinomycin—testicular cancer	0.00199	0.00199	CcSEcCtD
Potassium Canrenoate—Rash—Dactinomycin—testicular cancer	0.00197	0.00197	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Ifosfamide—testicular cancer	0.00196	0.00196	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Cisplatin—testicular cancer	0.00195	0.00195	CcSEcCtD
Potassium Canrenoate—Pain—Etoposide—testicular cancer	0.00193	0.00193	CcSEcCtD
Potassium Canrenoate—Haemoglobin—Methotrexate—testicular cancer	0.00192	0.00192	CcSEcCtD
Potassium Canrenoate—Haemorrhage—Methotrexate—testicular cancer	0.00191	0.00191	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Etoposide—testicular cancer	0.00186	0.00186	CcSEcCtD
Potassium Canrenoate—Nausea—Dactinomycin—testicular cancer	0.00186	0.00186	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Etoposide—testicular cancer	0.00185	0.00185	CcSEcCtD
Potassium Canrenoate—Vomiting—Ifosfamide—testicular cancer	0.00182	0.00182	CcSEcCtD
Potassium Canrenoate—Rash—Ifosfamide—testicular cancer	0.0018	0.0018	CcSEcCtD
Potassium Canrenoate—Dermatitis—Ifosfamide—testicular cancer	0.0018	0.0018	CcSEcCtD
Potassium Canrenoate—Haemoglobin—Epirubicin—testicular cancer	0.00179	0.00179	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Etoposide—testicular cancer	0.00179	0.00179	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Etoposide—testicular cancer	0.00179	0.00179	CcSEcCtD
Potassium Canrenoate—Haemorrhage—Epirubicin—testicular cancer	0.00178	0.00178	CcSEcCtD
Potassium Canrenoate—Asthenia—Cisplatin—testicular cancer	0.00177	0.00177	CcSEcCtD
Potassium Canrenoate—Nausea—Ifosfamide—testicular cancer	0.0017	0.0017	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Cisplatin—testicular cancer	0.00169	0.00169	CcSEcCtD
Potassium Canrenoate—Haemoglobin—Doxorubicin—testicular cancer	0.00166	0.00166	CcSEcCtD
Potassium Canrenoate—Haemorrhage—Doxorubicin—testicular cancer	0.00165	0.00165	CcSEcCtD
Potassium Canrenoate—Asthenia—Etoposide—testicular cancer	0.00162	0.00162	CcSEcCtD
Potassium Canrenoate—Arrhythmia—Epirubicin—testicular cancer	0.00159	0.00159	CcSEcCtD
Potassium Canrenoate—Vomiting—Cisplatin—testicular cancer	0.00157	0.00157	CcSEcCtD
Potassium Canrenoate—Rash—Cisplatin—testicular cancer	0.00156	0.00156	CcSEcCtD
Potassium Canrenoate—Dermatitis—Cisplatin—testicular cancer	0.00155	0.00155	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Etoposide—testicular cancer	0.00155	0.00155	CcSEcCtD
Potassium Canrenoate—Flatulence—Epirubicin—testicular cancer	0.00153	0.00153	CcSEcCtD
Potassium Canrenoate—Arrhythmia—Doxorubicin—testicular cancer	0.00147	0.00147	CcSEcCtD
Potassium Canrenoate—Nausea—Cisplatin—testicular cancer	0.00147	0.00147	CcSEcCtD
Potassium Canrenoate—Vomiting—Etoposide—testicular cancer	0.00144	0.00144	CcSEcCtD
Potassium Canrenoate—Rash—Etoposide—testicular cancer	0.00143	0.00143	CcSEcCtD
Potassium Canrenoate—Dermatitis—Etoposide—testicular cancer	0.00142	0.00142	CcSEcCtD
Potassium Canrenoate—Flatulence—Doxorubicin—testicular cancer	0.00142	0.00142	CcSEcCtD
Potassium Canrenoate—Discomfort—Methotrexate—testicular cancer	0.0014	0.0014	CcSEcCtD
Potassium Canrenoate—Confusional state—Methotrexate—testicular cancer	0.00137	0.00137	CcSEcCtD
Potassium Canrenoate—Infection—Methotrexate—testicular cancer	0.00135	0.00135	CcSEcCtD
Potassium Canrenoate—Nausea—Etoposide—testicular cancer	0.00134	0.00134	CcSEcCtD
Potassium Canrenoate—Discomfort—Epirubicin—testicular cancer	0.00131	0.00131	CcSEcCtD
Potassium Canrenoate—Confusional state—Epirubicin—testicular cancer	0.00128	0.00128	CcSEcCtD
Potassium Canrenoate—Hypotension—Methotrexate—testicular cancer	0.00127	0.00127	CcSEcCtD
Potassium Canrenoate—Infection—Epirubicin—testicular cancer	0.00126	0.00126	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Methotrexate—testicular cancer	0.00122	0.00122	CcSEcCtD
Potassium Canrenoate—Discomfort—Doxorubicin—testicular cancer	0.00121	0.00121	CcSEcCtD
Potassium Canrenoate—Hypotension—Epirubicin—testicular cancer	0.00118	0.00118	CcSEcCtD
Potassium Canrenoate—Confusional state—Doxorubicin—testicular cancer	0.00118	0.00118	CcSEcCtD
Potassium Canrenoate—Infection—Doxorubicin—testicular cancer	0.00116	0.00116	CcSEcCtD
Potassium Canrenoate—Pain—Methotrexate—testicular cancer	0.00116	0.00116	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Epirubicin—testicular cancer	0.00114	0.00114	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Methotrexate—testicular cancer	0.00112	0.00112	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Methotrexate—testicular cancer	0.00111	0.00111	CcSEcCtD
Potassium Canrenoate—Hypotension—Doxorubicin—testicular cancer	0.0011	0.0011	CcSEcCtD
Potassium Canrenoate—Pain—Epirubicin—testicular cancer	0.00108	0.00108	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Methotrexate—testicular cancer	0.00107	0.00107	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Methotrexate—testicular cancer	0.00107	0.00107	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Doxorubicin—testicular cancer	0.00105	0.00105	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Epirubicin—testicular cancer	0.00104	0.00104	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Epirubicin—testicular cancer	0.00104	0.00104	CcSEcCtD
Potassium Canrenoate—Pain—Doxorubicin—testicular cancer	0.001	0.001	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Epirubicin—testicular cancer	0.001	0.001	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Epirubicin—testicular cancer	0.001	0.001	CcSEcCtD
Potassium Canrenoate—Asthenia—Methotrexate—testicular cancer	0.000972	0.000972	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Doxorubicin—testicular cancer	0.000966	0.000966	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000959	0.000959	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Doxorubicin—testicular cancer	0.000927	0.000927	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Doxorubicin—testicular cancer	0.000927	0.000927	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Methotrexate—testicular cancer	0.000927	0.000927	CcSEcCtD
Potassium Canrenoate—Asthenia—Epirubicin—testicular cancer	0.000909	0.000909	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Epirubicin—testicular cancer	0.000867	0.000867	CcSEcCtD
Potassium Canrenoate—Vomiting—Methotrexate—testicular cancer	0.000861	0.000861	CcSEcCtD
Potassium Canrenoate—Rash—Methotrexate—testicular cancer	0.000854	0.000854	CcSEcCtD
Potassium Canrenoate—Dermatitis—Methotrexate—testicular cancer	0.000853	0.000853	CcSEcCtD
Potassium Canrenoate—Asthenia—Doxorubicin—testicular cancer	0.000841	0.000841	CcSEcCtD
Potassium Canrenoate—Vomiting—Epirubicin—testicular cancer	0.000806	0.000806	CcSEcCtD
Potassium Canrenoate—Nausea—Methotrexate—testicular cancer	0.000804	0.000804	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Doxorubicin—testicular cancer	0.000802	0.000802	CcSEcCtD
Potassium Canrenoate—Rash—Epirubicin—testicular cancer	0.000799	0.000799	CcSEcCtD
Potassium Canrenoate—Dermatitis—Epirubicin—testicular cancer	0.000798	0.000798	CcSEcCtD
Potassium Canrenoate—Nausea—Epirubicin—testicular cancer	0.000753	0.000753	CcSEcCtD
Potassium Canrenoate—Vomiting—Doxorubicin—testicular cancer	0.000746	0.000746	CcSEcCtD
Potassium Canrenoate—Rash—Doxorubicin—testicular cancer	0.000739	0.000739	CcSEcCtD
Potassium Canrenoate—Dermatitis—Doxorubicin—testicular cancer	0.000739	0.000739	CcSEcCtD
Potassium Canrenoate—Nausea—Doxorubicin—testicular cancer	0.000697	0.000697	CcSEcCtD
